Insider Transactions in Q1 2026 at Oramed Pharmaceuticals Inc. (ORMP)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 22
2026
|
Nadav Kidron President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
109,000
+3.15%
|
-
|
|
Jan 22
2026
|
Avraham Gabay Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+2.84%
|
-
|
|
Jan 22
2026
|
Miriam Kidron Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+1.29%
|
-
|
|
Jan 22
2026
|
Joshua Hexter COO & CBO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+1.75%
|
-
|
|
Jan 14
2026
|
Miriam Kidron Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
86,166
-6.03%
|
-
|